<html><head></head><body><h1>RE Iron Tablets</h1><p class="drug-subtitle"><b>Generic Name:</b> iron pentacarbonyl, folic acid, cyanocobalamin, ascorbic acid and docusate sodium<br/>
<b>Dosage Form:</b> tablet<br/></p><p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.</p><ul>
<li>Indications and Usage</li>
<li>Dosage and Administration</li>
<li>Contraindications</li>
<li>Warnings and Precautions</li>
<li>Adverse Reactions/Side Effects</li>
<li>Drug Interactions</li>
<li>Use In Specific Populations</li>
<li class="ddc-toggle-hidden">Overdosage</li>
<li class="ddc-toggle-hidden">Description</li>
<li class="ddc-toggle-hidden">Clinical Pharmacology</li>
<li class="ddc-toggle-hidden">Warnings</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
</ul><h2>Indications and Usage for RE Iron Tablets</h2><p>RE Iron Tablets 90mg is indicated for the prevention and treatment of iron deficiency anemia and/or nutritional megaloblastic anemias.</p><h2>RE Iron Tablets Dosage and Administration</h2><p>One tablet daily or as directed by a physician.</p><h2>Contraindications</h2><p>RE Iron Tablets 90mg is contraindicated in patients with known hypersensitivity to any of its ingredients. Folic acid (pteroylglutamic acid) is contraindicated in patients with untreated and uncomplicated pernicious anemia and in those with anaphylactic sensitivity to folic acid. Iron therapy is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron stage disease dude to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.) pyridoxine responsive anemia or cirrhosis of the liver.</p><h2>Warnings and Precautions</h2><h2>Adverse Reactions</h2><p class="First">Allergic sensitivity reactions and gastrointestinal disturbances may occur with iron therapy. Folic Acid allergic sensitization has been reported following both oral and parenteral administration.<br/>
<br/>
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.</p><h2>Drug Interactions</h2><p>There is a variety of iron/drug interactions which include antacids, tetracyclines, or fluoroquinolones.</p><h2>USE IN SPECIFIC POPULATIONS</h2><p class="First">Pediatric Use: Safety and effectiveness in pediatric patients have not been established.<br/>
<br/>
Geriatric Use: clinical studies on this product have not been performed in sufficient numbers of subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects,. In general, dose selection for an elderly patient should be made cautiously, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.</p><h2>Overdosage</h2><p class="First">The clinical course of acute iron overdosage can vary. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools, melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma.</p><h2>RE Iron Tablets Description</h2><h2>RE Iron Tablets - Clinical Pharmacology</h2><p class="First">Iron is necessary for the proper functioning of hemoglobin and red blood cell production.<br/>
Folic acid is required for cell division and growth and the maintenance of red blood cells.<br/>
Vitamin B12 is required for the maintenance of normal red blood cell synthesis, cell reproduction and normal growth. Intrinsic factor, a gastric protein secreted by the parietal cells, is required for the absorption of Vitamin B12 from the gastrointestinal tract.</p><h2>Warning</h2><p class="First">Pernicious anemia should be ruled out before starting treatment. While folic acid corrects the hematological profile or pernicious anemia, it does not ameliorate the underlying neurologic involvement.</p><h2>How Supplied/Storage and Handling</h2><p class="First">RE Iron Tablets 90 mg (NDC 68032-371-90) is a reddish-brown, modified rectangle shaped, film-coated tablet, debossed with “RE 371” on one side and blank on the other, and packaged in bottles of 90.<br/>
<br/>
Store at 25C (77F). Excursions permitted to 15-30C (59-86F). (See USP Controlled Room Temperature.)<br/>
NOTICE: Contact with moisture can discolor or erode the tablet. Do not chew tablet.</p><h2>PACKAGING</h2><h2>More about docusate / iron / multivitamin</h2><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Vitamin/Mineral Supplementation and Deficiency</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>